Detection of the mevalonate pathway in Streptomyces species using the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene.

T. Kuzuyama,Shunji Takahashi,T. Dairi,H. Seto

DOI: https://doi.org/10.7164/ANTIBIOTICS.55.919

2002-10-25

Abstract:Isoprenoids found in all living organisms comprise essential components of biological systems such as sterols, carotenoids, dolichols, ubiquinones and prenylated proteins. These compounds are synthesized by consecutive condensations of the five-carbon precursors, isopentenyl diphosphate (IPP), to its isomer, dimethylallyl diphosphate (DMAPP). Two distinct pathways for these precursors are known. One is the classical mevalonate pathway that operates in eucaryotes, archaebacteria and the cytosol of higher plants1). The other is a recently discovered pathway, the nonmevalonate pathway, which is used by many eubacteria including actinomycetes, green algae and the chloroplasts of higher plants1). To date, five reaction steps and the corresponding enzymes for this new pathway have been identified and characterized2). These findings raised an interesting question with regard to the biosynthesis of Isoprenoids by the genus Streptomyces which belongs to the actinomycetes, since some of the isoprenoid metabolites such as pentalenolactone3), carquinostatin4), longestin (KS-505a)5), novobiocin6,7), moenomycin8,9) and teleocidin10) were biosynthesized through the nonmevalonate pathway, while metabolites such as naphterpin11,12), furaquinocin13), napyradiomycin14) and terpentecin15) were proved to be of mevalonate pathway origin (Fig. 1). In addition, we have also shown that Streptomyces sp. strain CL190 (a naphterpin producer) utilizes the nonmevalonate pathway for the production of the primary metabolite, menaquinone, and that this organism switched to the mevalonate pathway for the biosynthesis of the secondary metabolite, naphterpin, at a later stage of fermentation12). To date, there seems to be no taxonomic criteria to distinguish Streptomyces species with the mevalonate pathway from those with only the nonmevalonate pathway. It should be noted that all the results cited above were obtained by laborious biosynthetic studies using expensive 13C-labeled